TNDM stock: buy or sell?

TNDM stock price: $64.27 2.72% At close on November 15th, 2019

Updated on:
November 15th, 2019

2

Shares of Tandem Diabetes Care ended yesterday at $64.27 and rose a very good 2.72%.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States.

Should I buy TNDM stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Following a trading strategy helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

Just 1 of our buy setups matches with Tandem Diabetes Care stock now:

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MAYes
100d MA crossing up 200d MANo

Is Tandem Diabetes Care stock a buy?

Banks and financial institutions publish stock ratings everyday. At Stocks2.com, we gathered 15 ratings published for TNDM stock in the last 30 days.

The general sentiment of these ratings is bullish for TNDM stock, with 10 positive ratings.
Is TNDM a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-8-2Oppenheimern/an/a
2019-6-17Lake Street Capitaln/aBuy
2019-5-17Bank of American/aNeutral
2019-5-17Bank of American/aNeutral
2019-5-1Oppenheimern/aOutperform
2019-4-30UBS GroupNeutralNeutral
2019-3-8BMO Capital Marketsn/aOutperform
2019-3-5Bank of American/aNeutral
2019-2-27Piper Jaffray Companiesn/aOverweight
2019-2-27Oppenheimern/aOutperform
2019-2-27Lake Street CapitalBuyBuy
2019-2-27Craig Hallumn/aBuy
2019-2-27Cowenn/aOutperform
2019-2-15Robert W. Bairdn/aOutperform
2019-2-15Robert W. Bairdn/aOutperform

TNDM stock analysis

Daily outlook

Tandem Diabetes Care shares rose 2.72% to $64.27 yesterday.

Tandem Diabetes Care shares rose 2.72% to $64.27 yesterday. Since price and SMA200d lines crossed up on Wednesday, TNDM climbed $2.84 (4.62%).

TNDM stock chart (daily)

Weekly outlook

After sliding a frightening -8.70% in a week last week, Tandem Diabetes Care closed this week at $64.27 and skyrocketed an astounding 12.05%.

This week TNDM price bounced up over the SMA of 40 weeks that acted as support stopping new slides.

TNDM stock chart (weekly)

TNDM stock price history

TNDM stock went public on November 14th, 2013 with a price of $195.001. Since then, TNDM stock declined a -67.00%, with a yearly average of -11.20%.

1: Adjusted price after possible price splits or reverse-splits.

TNDM stock historical price chart

TNDM stock reached 52-week highs on March at $74.81, and all-time highs 2014-01-14 with a price of 302.5.

TNDM stock price target is $70.50

How much a stock will be priced tomorrow or next week is quite unpredictable However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we found 14 price forecasts for Tandem Diabetes Care stock:
TNDM stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-8-2OppenheimerRaises Target$80.00$84.005%
2019-5-17Bank of AmericaReiteratesn/a$65.00-
2019-5-17Bank of AmericaRaises Target$65.00$75.0015.4%
2019-5-1OppenheimerRaises Target$68.00$80.0017.6%
2019-4-30UBS GroupRaises Target$53.00$66.0024.5%
2019-3-8BMO Capital MarketsInitiatesn/a$77.00-
2019-3-5Bank of AmericaRaises Target$59.00$65.0010.2%
2019-2-27Piper Jaffray CompaniesUpgradesn/a$67.00-
2019-2-27OppenheimerRaises Target$57.00$68.0019.3%
2019-2-27Lake Street CapitalRaises Target$60.00$100.0066.7%
2019-2-27Craig HallumReiterates$59.00$70.0018.6%
2019-2-27CowenReiterates$40.00$60.0050%
2019-2-15Robert W. BairdReiterates$46.00$55.0019.6%
2019-2-15Robert W. BairdRaises Target$46.00$55.0019.6%
(in average)$57.50$70.5023.0%
Moving in a range from $100.00 and $55.00, the price prediction for Tandem Diabetes Care stock is $70.50. In average, analysts' outlook on TNDM price forecast is positive, increasing the forecast by a 23.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

Since last February, when Tandem Diabetes Care posted its last earnings report, it . Unfortunately, reported EPS is not yet available in our database.
TNDM earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q2-n/a-4.36n/a
2017-Q32017-10-26-3.74-3.59n/a
2017-Q42018-03-01-1.28-1.23n/a
2018-Q12018-04-26-0.59-1.03n/a
2018-Q22018-07-30-0.35-0.34n/a
2018-Q32018-11-01-0.34-0.3n/a
2018-Q42019-02-26-0.220.02n/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a
2019-Q3-n/an/an/a

Annual financial results

In 2018, Tandem Diabetes Care annual revenues climbed an exceptional 70.88% to $183.87 million dollars from $107.60 marked in 2017. When comparing 2018 vs 2017, nonetheless, profit margin (that is, the net income divided by revenues) stepped up a 1.19% to -66.68%.

TNDM annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$29 M-$-63.14 M-217.6%-
2014$50 M71.40%$-79.52 M-159.9%25.95%
2015$73 M46.51%$-72.42 M-99.4%-8.94%
2016$84 M15.65%$-83.45 M-99.0%15.23%
2017$108 M27.72%$-73.03 M-67.9%-12.48%
2018$184 M70.88%$-122.61 M-66.7%67.88%

Quarterly financial results

Tandem Diabetes Care reported $76.20 million in revenues for 2018-Q4, a 64.70% improvement compared to previous quarter. Reported quarter earnings marked $3.69 million with a profit margin of 4.84%. Profit margin boosted a 78.86% compared to previous quarter when profit margin was -74.02%. When comparing revenues to same quarter last year, Tandem Diabetes Care sales marked an astounding growth and rocketed a 89.10%. Looking back to recent quarterly results, Tandem Diabetes Care posted 3 positive quarters in a row.
TNDM quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q2$21 M-$-21.80 M-102.2%-
2017-Q3$27 M26.60%$-16.04 M-59.4%-26.44%
2017-Q4$40 M49.22%$-11.41 M-28.3%-28.87%
2018-Q1$27 M-32.31%$-32.69 M-119.9%186.63%
2018-Q2$34 M25.11%$-59.36 M-173.9%81.56%
2018-Q3$46 M35.57%$-34.25 M-74.0%-42.31%
2018-Q4$76 M64.70%$3.69 M4.8%-110.77%
2019-Q1$66 M-13.39%$-22.99 M-34.8%-723.43%

Tandem Diabetes Care ownership

When you are planning to invest in a company, it's worth to overview its ownership structure.

Tandem Diabetes Care shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 5.14% of all shares.

Bearish positions for TNDM stock account 0.00%, no big difference from last month.

For a better understanding, the next table shows ownership data compared to other related stocks:

TNDMDXCMICUIJNJMDT
Market cap$3.8 B$19.1 B$3.6 B$354.9 B$150.2 B
Total shares59.1 M91.5 M20.7 M2,630.0 M1,340.0 M
Float shares56.6 M90.3 M19.2 M2,630.0 M1,340.0 M
  - Institutional holdings (%)89.9%100.2%93.5%69.2%84.2%
  - Insider holdings (%)5.1%1.1%7.1%0.1%0.1%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

TNDM summary

Friday, November 15th, 2019
Open$63.18
Close$64.27
Day range$62.74 - $64.39
Previous close$62.57
Session gain2.72%
Average true range$3.36
50d mov avg$60.69
100d mov avg$62.54
200d mov avg$62.46
Daily pattern
Weekly pattern

Tandem Diabetes Care performance

To better understand Tandem Diabetes Care performance you must compare its gains with other related stocks in same sector or industry. In the following table, we compare Tandem Diabetes Care performance to DexCom, ICU Medical, , Medtronic and Insulet:
Stock3m6m12m
TNDMTandem Diabetes C...9.38%-4.26%91.91%
DXCMDexCom27.30%76.52%50.83%
ICUIICU Medical5.09%-22.33%-28.06%
JNJ3.50%-1.24%-5.02%
MDTMedtronic9.60%29.09%22.22%
PODDInsulet20.03%73.57%120.22%

Tandem Diabetes Care competitors

One check before trading any stock is to have a look a list of its competitors, in this case for Tandem Diabetes Care. We chose 5 companies as Tandem Diabetes Care competitors as they are in the same industry or have similar market objectives.